Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal ketamine versus tramadol as additives to bupivacaine for spinal anesthesia
IRCT20230813059138N1Phase 3Completed
- Sponsor
- Faculty of Medicine Ibn Al Jazzar of Sousse
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine, tramadol and bupivacaine in procedural pain (3 arms), sponsored by Faculty of Medicine Ibn Al Jazzar of Sousse. Primary endpoints: onset of sensory block, duration of sensory block and 10 more. Started Aug 2023; status: completed.
02
Drugs
ketaminetramadolbupivacaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on IRCT20230813059138N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230813059138N1.